Transglutaminase 2 inhibits apoptosis induced by calciumoverload through down-regulation of Bax

Experimental and Molecular Medicine

Volumn 42, Issue 9, 2010, Pages 639-650

  Cho, Sung Yup ^a   Lee, Jin Haeng ^a   Bae, Han Dong ^a   Jeong, Eui Man ^a   Jang, Gi Yong ^a   Kim, Chai Wan ^a   Shin, Dong Myung ^a   Jeon, Ju Hong ^b   Kim, In Gyu ^a  

^a Aging and Apoptosis Research Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Bax; Calcium; Mitochondria; Transglutaminase 2

Indexed keywords

CALCIUM; CASPASE 3; CASPASE 9; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

AMIDATION; AMINATION; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL HYPOXIA; CELL STRAIN HEK293; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; CYTOSOL; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME RELEASE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; OXIDATIVE STRESS; PROTEIN FAMILY; WESTERN BLOTTING;

EID: 77957727111     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2010.42.9.063     Document Type: Article

References (48)

1. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 2002; 9:423-32
2. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000; 148:825-38
3. Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, Page RL, Cerione RA. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 2001; 276:33582-7
4. Antonyak MA, McNeill CJ, Wakshlag JJ, Boehm JE, Cerione RA. Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J Biol Chem 2003; 278:15859-66
5. Antonyak MA, Miller AM, Jansen JM, Boehm JE, Balkman CE, Wakshlag JJ, Page RL, Cerione RA. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 2004; 279:41461-7
6. Battaglia G, Farrace MG, Mastroberardino PG, Viti I, Fimia GM, Van Beeumen J, et al. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. J Neurochem 2007; 100:36-49
7. Boehm JE, Singh U, Combs C, Antonyak MA, Cerione RA. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 2002; 277:20127-30
8. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550-3
9. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22:8590-607
10. De Laurenzi V, Melino G. Gene disruption of tissue trans-glutaminase. Mol Cell Biol 2001; 21:148-55
11. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA. Calcium in cell injury and death. Annu Rev Pathol 2006; 1: 405-34
12. Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 1987; 224:104-8
13. Fesus L, Davies PJ, Piacentini M. Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol 1991; 56:170-7
14. Fesus L, Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 2005; 579:3297-302
15. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998; 94:695-8
16. Gu JJ, Gathy K, Santiago L, Chen E, Huang M, Graves LM, Mitchell BS. Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. Blood 2003; 101:4958-65
17. Gundemir S, Johnson GV. Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS One 2009; 4:e6123
18. Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reperfusion injury. Ann N Y Acad Sci 2005; 1047: 248-58
19. Humar M, Graetz C, Roesslein M, Goebel U, Geiger KK, Heimrich B, Pannen BH. Heterocyclic thioureylenes protect from calcium-dependent neuronal cell death. Mol Pharmacol 2009; 75:667-76
20. Hwa Kim S, Hoon Jeong J, Chul Cho K, Wan Kim S, Gwan Park T. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release 2005; 104:223-32
21. Jang GY, Jeon JH, Cho SY, Shin DM, Kim CW, Jeong EM, Bae HC, Kim TW, Lee SH, Choi Y, Lee DS, Park SC, Kim IG. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Oncogene 2010; 29:356-67
22. Jang H, Choi SY, Cho EJ, Youn HD. Cabin1 restrains p53 activity on chromatin. Nat Struct Mol Biol 2009; 16:910-5
23. Jeon JH, Kim CW, Shin DM, Kim K, Cho SY, Kwon JC, Choi KH, Kang HS, Kim IG. Differential incorporation of biotinylated polyamines by transglutaminase 2. FEBS Lett 2003; 534:180-4
24. Kweon SM, Lee ZW, Yi SJ, Kim YM, Han JA, Paik SG, Ha SS. Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells. J Biochem Mol Biol 2004; 37:185-91
25. Lee SK, Kim YS, Lee SS, Lee YJ, Song IS, Park SC, Chi JG, Chung SI. Antisense inhibition of transglutaminase 2 affects development of mouse embryo submandibular gland in organ culture. Arch Oral Biol 2005; 50:789-98
26. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4:140-56
27. Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, et al. The adenine nucleotide translo-cator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ 2009; 16:1480-92
28. Mastroberardino PG, Farrace MG, Viti I, Pavone F, Fimia GM, Melino G, Rodolfo C, Piacentini M. Tissue transglu-taminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes. Biochim Biophys Acta 2006; 1757:1357-65
29. Milakovic T, Tucholski J, McCoy E, Johnson G V. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 2004; 279: 8715-22
30. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 1994; 264:1593-6
31. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM. Targeted inactivation of Gh/tissue transgluta-minase II. J Biol Chem 2001; 276:20673-8
32. Oliverio S, Amendola A, Rodolfo C, Spinedi A, Piacentini M. Inhibition of tissue transglutaminase increases cell survival by preventing apoptosis. J Biol Chem 1999; 274:34123-8
33. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4:552-65
34. Park KS, Han BG, Lee KH, Kim DS, Kim JM, Jeon H, et al. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Lett 2008; 274:201-7
35. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116:1409-16
36. Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasca L, et al. Transglutaminase over-expression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem 2002; 81:1061-72
37. Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003; 22:395-403
38. Robitaille K, Daviau A, Lachance G, Couture JP, Blouin R. Calphostin C-induced apoptosis is mediated by a tissue transglutaminase-dependent mechanism involving the DLK/JNK signaling pathway. Cell Death Differ 2008; 15: 1522-31
39. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, Piacentini M. Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 2004; 279:54783-92
40. Shin DM, Jeon JH, Kim CW, Cho SY, Lee HJ, Jang GY, et al. TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J 2008; 22:2498-507
41. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 2003; 278: 391-9
42. Slaughter TF, Achyuthan KE, Lai TS, Greenberg CS. A microtiter plate transglutaminase assay utilizing 5-(bioti-namido)pentylamine as substrate. Anal Biochem 1992; 205: 166-71
43. Szondy Z, Mastroberardino PG, Váradi J, Farrace MG, Nagy N, Bak I, et al. Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis. Cell Death Differ 2006; 13:1827-9
44. Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, Iismaa S, Matsuura T, Tsukamoto H, Zern MA, Graham RM, Kojima S. Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 2009; 136:1783-95
45. Tucholski J, Johnson G V. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J Neurochem 2002; 81:780-91
46. Tucholski J. TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation. Amino Acids 2010; 39:523-32
47. Waterhouse NJ, Goldstein JC, Kluck RM, Newmeyer DD, Green DR. The (Holey) study of mitochondria in apoptosis. Methods Cell Biol 2001; 66:365-91
48. Wei MC, Zong WX, Cheng EH, Lindsten T, Panou-tsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-30